Effect of 5-Oxo-2-Pyrrolidinecarboxylic Acid (PCA) as a New Topically Applied Agent for Dry Eye Syndrome Treatment

The aim of the study was the evaluation of the suitability of 5-oxo-2-pyrrolidinecarboxylic acid (PCA), also in combination with hyaluronic acid (HA), as artificial tears for treatment of dry eye syndrome (DES). Different aqueous formulations containing 0.10% w/w of PCA were used to determine: (i) e...

Descripción completa

Detalles Bibliográficos
Autores principales: Tampucci, Silvia, Monti, Daniela, Burgalassi, Susi, Terreni, Eleonora, Zucchetti, Erica, Baldacci, Filippo, Chetoni, Patrizia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161197/
https://www.ncbi.nlm.nih.gov/pubmed/30149648
http://dx.doi.org/10.3390/pharmaceutics10030137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161197/
https://www.ncbi.nlm.nih.gov/pubmed/30149648
http://dx.doi.org/10.3390/pharmaceutics10030137

Ejemplares similares